Stevens Capital Management’s Emergent Biosolutions EBS Stock Holding History

Stevens Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-23,806	Closed	-$691K	–	894
2017 Q1	$691K	Buy	+23,806	New	+$725K	0.03%	504
2016 Q3	–	Sell	-8,107	Closed	-$228K	–	954
2016 Q2	$228K	Buy	+8,107	New	+$318K	0.01%	743
2015 Q4	–	Sell	-16,881	Closed	-$481K	–	974
2015 Q3	$481K	Buy	+16,881	New	+$556K	0.02%	544
2015 Q2	–	Sell	-16,735	Closed	-$481K	–	1075
2015 Q1	$481K	Buy	+16,735	New	+$480K	0.02%	591
2013 Q4	–	Sell	-13,894	Closed	-$265K	–	1057
2013 Q3	$265K	Buy	+13,894	New	+$248K	0.01%	828

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return